Clinical trials
Phase 2/3 trials in Chile
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 7 |
| 2021 | 6 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 8 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Recruiting | 20 |
| Terminated | 10 |
| Active, not recruiting | 8 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 9 |
| Bristol-Myers Squibb | 7 |
| Sanofi | 6 |
| AbbVie | 3 |
| BioNTech SE | 2 |
| Boehringer Ingelheim | 2 |
| Hoffmann-La Roche | 2 |
| Novartis Vaccines | 2 |
| Pfizer | 2 |
| ACADIA Pharmaceuticals Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 5 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Lung Neoplasms | 3 |
| Amyotrophic Lateral Sclerosis | 2 |
| Colitis, Ulcerative | 2 |
| Hypertension | 2 |
| Infections | 2 |
| Meningococcal Infections | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
Trials
Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.